相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Effects of PMM2-CDG-Causing Mutations on the Folding, Activity, and Stability of the PMM2 Protein
Patricia Yuste-Checa et al.
HUMAN MUTATION (2015)
PAINS in the Assay: Chemical Mechanisms of Assay Interference and Promiscuous Enzymatic Inhibition Observed during a Sulfhydryl-Scavenging HTS
Jayme L. Dahlin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Phosphomannomutase deficiency (PMM2-CDG): ataxia and cerebellar assessment
Mercedes Serrano et al.
ORPHANET JOURNAL OF RARE DISEASES (2015)
Solving Glycosylation Disorders: Fundamental Approaches Reveal Complicated Pathways
Hudson H. Freeze et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2014)
The essential roles of chemistry in high-throughput screening triage
Jayme L. Dahlin et al.
FUTURE MEDICINAL CHEMISTRY (2014)
The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine
Peter D. Stenson et al.
HUMAN GENETICS (2014)
Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators
Ania C. Muntau et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2014)
Chemical con artists foil drug discovery
Jonathan Baell et al.
NATURE (2014)
Gaucher iPSC-Derived Macrophages Produce Elevated Levels of Inflammatory Mediators and Serve as a New Platform for Therapeutic Development
Leelamma M. Panicker et al.
STEM CELLS (2014)
Neuronopathic Gaucher's disease: induced pluripotent stem cells for disease modelling and testing chaperone activity of small compounds
Gustavo Tiscornia et al.
HUMAN MOLECULAR GENETICS (2013)
Pharmacological chaperones as a potential therapeutic option in methylmalonic aciduria cblB type
Ana Jorge-Finnigan et al.
HUMAN MOLECULAR GENETICS (2013)
Biochemical phenotype of a common disease-causing mutation and a possible therapeutic approach for the phosphomannomutase 2-associated disorder of glycosylation
Giuseppina Andreotti et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2013)
Pharmacological chaperones for enzyme enhancement therapy in genetic diseases
Juan Aymami et al.
PHARMACEUTICAL PATENT ANALYST (2013)
Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation
Tihomir Tomasic et al.
EXPERT OPINION ON DRUG DISCOVERY (2012)
Chemical and Biological Properties of Frequent Screening Hits
Jianwei Che et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Small Molecules That Target Protein Misfolding
Lori Krim Gavrin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Successful prenatal mannose treatment for congenital disorder of glycosylation-Ia in mice
Anette Schneider et al.
NATURE MEDICINE (2012)
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade
Christine E. Bulawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Phosphomannose Isomerase Inhibitors Improve N-Glycosylation in Selected Phosphomannomutase-deficient Fibroblasts
Vandana Sharma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Congenital disorders of glycosylation
Jaak Jaeken
YEAR IN HUMAN AND MEDICAL GENETICS: NEW TRENDS IN MENDELIAN GENETICS (2010)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Biological and Chemical Approaches to Diseases of Proteostasis Deficiency
Evan T. Powers et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2009)
The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia)
Stephanie Grunewald
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Towards a therapy for phosphomannomutase 2 deficiency, the defect in CDG-Ia patients
Hudson H. Freeze
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Functional Analysis of Three Splicing Mutations Identified in the PMM2 Gene: Toward a New Therapy for Congenital Disorder of Glycosylation type IA
Ana I. Vega et al.
HUMAN MUTATION (2009)
A counterintuitive approach to treat enzyme deficiencies: use of enzyme inhibitors for restoring mutant enzyme activity
Jian-Qiang Fan
BIOLOGICAL CHEMISTRY (2008)
Chemical and biological approaches synergize to ameliorate protein-folding diseases
Ting-Wei Mu et al.
CELL (2008)
Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria
Angel L. Pey et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study
Harvey L. Levy et al.
LANCET (2007)
Central nervous system drug disposition: The relationship between in situ brain permeability and brain free fraction
Scott G. Summerfield et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability
Frank H. Niesen et al.
NATURE PROTOCOLS (2007)
Targeted disruption of the mouse phosphomannomutase 2 gene causes early embryonic lethality
Christian Thiel et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Protein production by auto-induction in high-density shaking cultures
FW Studier
PROTEIN EXPRESSION AND PURIFICATION (2005)
ALARM NMR: A rapid and robust experimental method to detect reactive false positives in biochemical screens
JR Huth et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Phenylketonuria:: Genotype-phenotype correlations based on expression analysis of structural and functional mutations in PAH
AL Pey et al.
HUMAN MUTATION (2003)
Enzyme replacement and enhancement therapies: Lessons from lysosomal disorders
RJ Desnick et al.
NATURE REVIEWS GENETICS (2002)
Pharmacokinetically based mapping device for chemical space navigation
TI Oprea et al.
JOURNAL OF COMBINATORIAL CHEMISTRY (2002)
High residual activity of PMM2 in patients' fibroblasts:: Possible pitfall in the diagnosis of CDG-Ia (phosphomannomutase deficiency)
S Grünewald et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia)
E Schollen et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2000)
分享论文
